loading
Schlusskurs vom Vortag:
$2.19
Offen:
$2.23
24-Stunden-Volumen:
108.05K
Relative Volume:
0.80
Marktkapitalisierung:
$97.28M
Einnahmen:
$106.79M
Nettoeinkommen (Verlust:
$-8.73M
KGV:
-16.92
EPS:
-0.13
Netto-Cashflow:
$10.81M
1W Leistung:
+1.85%
1M Leistung:
-5.17%
6M Leistung:
-30.38%
1J Leistung:
-50.45%
1-Tages-Spanne:
Value
$2.185
$2.29
1-Wochen-Bereich:
Value
$2.09
$2.40
52-Wochen-Spanne:
Value
$1.99
$5.56

Harvard Bioscience Inc Stock (HBIO) Company Profile

Name
Firmenname
Harvard Bioscience Inc
Name
Telefon
(508) 893-8999
Name
Adresse
84 OCTOBER HILL RD, HOLLISTON, MA
Name
Mitarbeiter
416
Name
Twitter
Name
Nächster Verdiensttermin
2024-11-07
Name
Neueste SEC-Einreichungen
Name
HBIO's Discussions on Twitter

Vergleichen Sie HBIO mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Medical Instruments & Supplies icon
HBIO
Harvard Bioscience Inc
2.20 97.28M 106.79M -8.73M 10.81M -0.13
Medical Instruments & Supplies icon
ISRG
Intuitive Surgical Inc
538.55 192.83B 7.87B 2.24B 586.00M 4.25
Medical Instruments & Supplies icon
BDX
Becton Dickinson Co
221.98 64.77B 20.18B 1.73B 3.07B 5.51
Medical Instruments & Supplies icon
ALC
Alcon Inc
88.23 43.75B 9.76B 1.16B 665.00M 0.72
Medical Instruments & Supplies icon
RMD
Resmed Inc
249.33 36.84B 4.81B 1.11B 1.35B 6.16
Medical Instruments & Supplies icon
WST
West Pharmaceutical Services Inc
323.32 23.33B 2.88B 499.60M 321.60M 7.41

Harvard Bioscience Inc Stock (HBIO) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2023-03-10 Hochstufung The Benchmark Company Speculative Buy → Buy
2021-01-07 Hochstufung The Benchmark Company Speculative Buy → Buy
2020-12-09 Eingeleitet Northland Capital Outperform
2020-11-10 Eingeleitet KeyBanc Capital Markets Overweight
2019-07-08 Herabstufung Janney Buy → Neutral
2018-01-24 Bestätigt Janney Buy
2018-01-23 Bestätigt The Benchmark Company Buy
2016-11-17 Eingeleitet Singular Research Buy
2015-07-28 Eingeleitet The Benchmark Company Buy
Alle ansehen

Harvard Bioscience Inc Aktie (HBIO) Neueste Nachrichten

pulisher
Nov 22, 2024

Harvard Bioscience (HBIO) Stock Surges Amid Positive Analyst Rat - GuruFocus.com

Nov 22, 2024
pulisher
Nov 21, 2024

HBIO stock touches 52-week low at $1.99 amid market challenges - Investing.com Australia

Nov 21, 2024
pulisher
Nov 20, 2024

HBIO stock touches 52-week low at $1.99 amid market challenges By Investing.com - Investing.com South Africa

Nov 20, 2024
pulisher
Nov 18, 2024

Harvard Bioscience, Inc. (NASDAQ:HBIO) Short Interest Up 13.8% in October - MarketBeat

Nov 18, 2024
pulisher
Nov 18, 2024

Ayla Majid becomes first South Asian ACCA president - The Accountant Online

Nov 18, 2024
pulisher
Nov 15, 2024

Harvard Bioscience (HBIO) Stock Drops Amid Industry Downturn - GuruFocus.com

Nov 15, 2024
pulisher
Nov 14, 2024

272 Capital LP Increases Stake in Harvard Bioscience Inc - GuruFocus.com

Nov 14, 2024
pulisher
Nov 12, 2024

HBIO stock touches 52-week low at $2.29 amid market challenges - Investing.com India

Nov 12, 2024
pulisher
Nov 12, 2024

Harvard Bioscience (HBIO) Stock Dips Amid Market Volatility - GuruFocus.com

Nov 12, 2024
pulisher
Nov 11, 2024

Harvard Bioscience, Inc. (NASDAQ:HBIO) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 11, 2024
pulisher
Nov 09, 2024

Harvard Bioscience Third Quarter 2024 Earnings: Misses Expectations - Yahoo Finance

Nov 09, 2024
pulisher
Nov 08, 2024

Harvard Bioscience (HBIO) Stock Surges with Positive Analyst Rat - GuruFocus.com

Nov 08, 2024
pulisher
Nov 08, 2024

Harvard Bioscience Inc (HBIO) Quarterly 10-Q Report - Quartzy

Nov 08, 2024
pulisher
Nov 08, 2024

SEC Form 10-Q filed by Harvard Bioscience Inc. - Quantisnow

Nov 08, 2024
pulisher
Nov 08, 2024

Harvard Bioscience Inc (HBIO) Q3 2024 Earnings Call Highlights: Navigating Challenges and ... By GuruFocus - Investing.com Canada

Nov 08, 2024
pulisher
Nov 07, 2024

Harvard Bioscience: Q3 Earnings Snapshot - CT Insider

Nov 07, 2024
pulisher
Nov 07, 2024

Harvard Bioscience, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 07, 2024
pulisher
Nov 07, 2024

3 Promising US Penny Stocks With At Least $100M Market Cap - Simply Wall St

Nov 07, 2024
pulisher
Nov 07, 2024

Harvard Bioscience Inc Reports Q3 2024 Revenue of $22.0M, Misses Estimates; EPS Loss of $0.11 - GuruFocus.com

Nov 07, 2024
pulisher
Nov 07, 2024

Harvard Bioscience : Q32024 HBIO Quarterly Earnings Presentation - Marketscreener.com

Nov 07, 2024
pulisher
Nov 07, 2024

Harvard Bioscience Announces Third Quarter 2024 Financial Results - GlobeNewswire

Nov 07, 2024
pulisher
Nov 06, 2024

Harvard Bioscience Inc (HBIO) Q3 2024 Earnings Report Preview: W - GuruFocus.com

Nov 06, 2024
pulisher
Nov 06, 2024

Harvard Bioscience Inc (HBIO) Q3 2024 Earnings Report Preview: What To Expect - Yahoo Finance

Nov 06, 2024
pulisher
Nov 01, 2024

Is It Too Late To Consider Buying Harvard Bioscience, Inc. (NASDAQ:HBIO)? - Yahoo Finance

Nov 01, 2024
pulisher
Oct 31, 2024

Zacks Industry Outlook Highlights Mettler-Toledo International and Harvard Bioscience - Yahoo Finance

Oct 31, 2024
pulisher
Oct 31, 2024

Harvard Bioscience (HBIO) Set to Announce Earnings on Thursday - MarketBeat

Oct 31, 2024
pulisher
Oct 30, 2024

Moolec Science (MLEC) versus Its Rivals Head-To-Head Comparison - Defense World

Oct 30, 2024
pulisher
Oct 30, 2024

Chegg, Inc. (NYSE:CHGG) Receives Consensus Rating of “Reduce” from Brokerages - Defense World

Oct 30, 2024
pulisher
Oct 30, 2024

Harvard Bioscience Schedules Third Quarter 2024 Earnings Conference Call for November 7, 2024 at 8:00 AM ET - The Manila Times

Oct 30, 2024
pulisher
Oct 29, 2024

2 Instruments Stocks to Watch From a Challenging Industry - Yahoo Finance

Oct 29, 2024
pulisher
Oct 23, 2024

HBIO stock touches 52-week low at $2.31 amid market challenges - Investing.com India

Oct 23, 2024
pulisher
Oct 14, 2024

Electroporation Instruments Market Analysis by Trends, - openPR

Oct 14, 2024
pulisher
Oct 11, 2024

HBIO stock touches 52-week low at $2.33 amid market challenges - Investing.com Australia

Oct 11, 2024
pulisher
Oct 09, 2024

Harvard Bioscience Inc (HBIO) Q2 2024 Earnings Call Highlights: Navigating Challenges with Strategic Initiatives - GuruFocus.com

Oct 09, 2024
pulisher
Oct 09, 2024

Harvard Bioscience Inc (HBIO) Q2 2024 Earnings Call Highlights: Navigating Challenges with ... By GuruFocus - Investing.com Canada

Oct 09, 2024
pulisher
Oct 06, 2024

Laboratory Centrifuge Market Innovations Investigated by Insights: Technological Advancements and Market Gr... - WhaTech

Oct 06, 2024
pulisher
Oct 05, 2024

Institutional owners may take dramatic actions as Harvard Bioscience, Inc.'s (NASDAQ:HBIO) recent 12% drop adds to one-year losses - Simply Wall St

Oct 05, 2024
pulisher
Oct 04, 2024

Annual Sustainability Report - Harvard University

Oct 04, 2024
pulisher
Oct 04, 2024

Editas trades part of Vertex CRISPR therapy licencing rights deal for $57m - Pharmaceutical Technology

Oct 04, 2024
pulisher
Oct 03, 2024

HBIO stock touches 52-week low at $2.49 amid market challenges By Investing.com - Investing.com South Africa

Oct 03, 2024
pulisher
Oct 03, 2024

HBIO stock touches 52-week low at $2.49 amid market challenges - Investing.com

Oct 03, 2024
pulisher
Oct 03, 2024

HBIO Stock Drops Amidst Market Fluctuations - GuruFocus.com

Oct 03, 2024

Finanzdaten der Harvard Bioscience Inc-Aktie (HBIO)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Harvard Bioscience Inc-Aktie (HBIO) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Green James W
Chief Executive Officer
Jun 06 '24
Buy
3.07
20,000
61,400
3,101,091
$21.04
price up icon 0.14%
medical_instruments_supplies BAX
$33.31
price up icon 1.34%
$229.66
price up icon 0.76%
$79.44
price up icon 0.56%
medical_instruments_supplies COO
$103.43
price up icon 0.77%
medical_instruments_supplies WST
$323.32
price up icon 1.24%
Kapitalisierung:     |  Volumen (24h):